Insulin Pump Choices update – April 2022

The pump options in Australia keep evolving, and it’s time for an update of two articles on this site:

Insulin Pump Choices

  • Tandem’s introduction of Control-IQ.
  • Sundry tweaks to the entries for other pumps.
  • Equil (not available in Australia)

Closed-loop pumps in Australia

The DIY options have not changed significantly recently, but there have been some updates:

  • Tandem’s Control-IQ
  • Further commentary on using Libre2 and Medtronic 770G/780G pumps as CGM sources.
  • Further mention of FreeAPS X.
  • Omnipod DASH support (only in development/testing versions) in Loop and FreeAPS X.
  • CamAPS HX

I’m sure the developments for 2022 haven’t finished, but that’ll do for now.

2 thoughts on “Insulin Pump Choices update – April 2022”

  1. I’m left wondering whether having glucagon available at the same time as the insulin is available improves the action of insulin, or is it to reduce the incidence of hypos.

    1. You’re referring to the iLet Bionic Pancreas?

      Glucagon is a hormone (normally produced by the alpha cells in the pancreas) that signals the liver to release glucose into the bloodstream, and the basic idea is that like in a person without T1D, the glucagon and insulin can be used as up/down controls in order to balance the system and yes reduce the likelihood of hypos. There are however lots of complications (such as the liver not having an infinite store of glycogen which is what it uses to convert back into glucose, the liver ignoring the glucagon in the presence of toxins such as alcohol, etc).

Leave a Comment

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.